We also explored the differential expression of the 5 proliferation genes included in the ODX-DCIS panel and did not find significant differences between the outcome groups (Supplemental Figure S7) in our RNA-Sequencing-based assessment. Here, FAHD1 is linked to ductal breast carcinoma in situ.